A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...

Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...

The combination demonstrated non-inferiority to comparator antiretroviral therapies, meeting the primary efficacy success ...

An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...

Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. | Immunocore’s big swing for a functional HIV ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...